eISSN: 2081-2833
ISSN: 2081-0016
Medycyna Paliatywna/Palliative Medicine
Current issue Archive About the journal Abstracting and indexing Subscription Contact Instructions for authors
3/2017
vol. 9
 
Share:
Share:
more
 
 
abstract:
Original paper

Management of healthcare-associated infections at the end of life – a cross-sectional study

Tomasz Grądalski, Barbara Burczyk-Fitowska

Medycyna Paliatywna 2017; 9(3): 152–156
Online publish date: 2018/02/01
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
A retrospective chart review was performed on 1458 patients admitted to the free-standing hospice between 1 September 2013 and 31 January 2016. A total of 134 (9.2%) patients (123 with advanced cancer) were clinically diagnosed with 172 cases of various healthcare-associated infections (HAI): two, three, and four times in 26, 5, and 1 person/s, respectively. The median length of care within the infected group was 32.0 days (vs. 9.6 days for non-infected). The most prominent infection risk factors identified were prolonged steroid therapy (37.0% of episodes), antibiotics used before the admission (23.7%), and bladder catheterisation (23.9%). The most common types of HAI were lower respiratory tract infection (LRTI; 43.0%), end-of-life infection of unknown origin (EOL-IUO), urinary tract infection (UTI) (17.4% each), and Clostridium difficile-associated diarrhoea (9.9%). Antibiotics most often used were gentamicin (once-only dosage) in EOL-PUO (27.9% of episodes), ceftriaxone in LRTI (17.4%), and levofloxacin in UTI (15.7%). In 18.0% of cases a sequence of two antibiotics was required. In 4.0% of episodes a sole symptomatic therapy was continued. Clinically meaningful improvement after the full course of antimicrobials was achieved in 79.5% of cases. Once-only antimicrobial was still efficacious but less so (52.1%, p = 0.0006) and comparable with sole symptomatic treatment (p = 0.7). The cost of antibiotics was 16.7% of all drug expenses. Antibiotic therapy appeared to be a frequently chosen, effective although expensive symptomatic management at the end of life.
keywords:

infections, antimicrobials, palliative care

references:
Homsi J, Walsh D, Panta R, et al. Infectious complications of advanced cancer. Support Care Cancer 2000; 8: 487-492.
Chun ED, Rodgers PE, Vitale CA, et al. Antimicrobial use among patients receiving palliative care consultation. Am J Hosp Palliat Care 2010; 27: 261-265.
Thompson AJ, Silveira MJ, Vitale CA, et al. Antimicrobial use at the end of life among hospitalized patients with advanced cancer. Am J Hosp Palliat Care 2012; 29: 599-603.
Yates E, Mitchell SL, Habtemariam D, et al. Interventions Associated With the Management of Suspected Infections in Advanced Dementia. J Pain Symptom Manage 2015; 50: 806-813.
Stosor V, Zembower TR (eds.). Infectious Complications in Cancer Patients. Cancer Treatment and Research. Springer International Publishing, Cham 2014.
Gold Standards Framework. Retrieved from: http://www.goldstandardsframework.org.uk/.
Stone ND, Ashraf MS, Calder J, et al. Surveillance Definitions of Infections in Long-Term Care Facilities: Revisiting the McGeer Criteria. Infect Control Hosp Epidemiol 2012; 33: 965-977.
Wójkowska-Mach J, Gryglewska B, Grodzicki T, et al. Definitions of infection in acute care hospitals and in long term care facilities. Gerontol Pol 2010; 18: 10-15.
Gutmanis I, Shadd J, Woolmore-Goodwin S, et al. Prevalence and indications for bladder catheterization on a palliative care unit: a prospective, observational study. Palliat Med 2014; 28: 1239-1240.
Wójkowska-Mach J, Gryglewska B, Czekaj J, et al. Infection control: point prevalence study versus incidence study in Polish long-term care facilities in 2009–2010 in the Małopolska Region. Infection 2013; 41: 1-8.
Nagy-Agren S, Haley HB. Management of infections in palliative care patients with advanced cancer. J Pain Symptom Manage 2002; 24: 64-70.
Vitetta L, Kenner D, Sali A. Bacterial infections in terminally ill hospice patients. J Pain Symptom Manage 2000; 20: 326-334.
Thai V, Lau F, Wolch G, et al. Impact of infections on the survival of hospitalized advanced cancer patients. J Pain Symptom Manage 2012; 43: 549-557.
White PH, Kuhlenschmidt HL, Vancura BG, et al. Antimicrobial use in patients with advanced cancer receiving hospice care. J Pain Symptom Manage 2003; 25: 438-443.
Mitchel BG, Ferguson JK, Anderson M, et al. Length of stay and mortality associated with healthcare-associated urinary tract infections: a multi-state model. J Hospital Infection 2016; 93: 92-99.
Yajima R, Ise Y, Wako T, et al. A Retrospective Study of Risk Factors for Infection in Cancer Patients Receiving Specialist Palliative Care. J Nippon Med Sch 2013; 80: 481-485.
Wójkowska-Mach J, Gryglewska B, Romaniszyn D, et al. Age and other risk factors of pneumonia among residents of Polish long-term care facilities. Int J Infect Dis 2013; 17: e37-e43.
Homsi J, Walsh D, Panta R, et al. Infectious complications of advanced cancer. Support Care Cancer 2000; 8: 487-492.
Yu H, Baser O, Wang L. Burden of Clostridium difficile-associated disease among patients residing in nursing homes: a population-based cohort study. Geriatrics 2016; 16: 193.
Thipmontree W, Kiratisin P, Manatsathit S, et al. Epidemiology of suspected Clostridium difficile-associated hospital-acquired diarrhea in hospitalized patients at Siriraj Hospital. J Med Assoc Thai 2011; 94 Suppl 1: S207-216.
Toussaint E, Bahel-Ball E, Vekemans M, et al. Causes of fever in cancer patients (prospective study over 477 episodes). Support Care Cancer 2006; 14: 763-769.
Abrutyn E, Mossey J, Berlin JA, et al. Does asymptomatic bacteriuria predict mortality and does antimicrobial treatment reduce mortality in elderly ambulatory women? Ann Intern Med 1994; 120: 827-833.
Schmalz O, Strapatsas T, Alefelder C, et al. Methicillin-resistant Staphylococcus aureus in palliative care: A prospective study of Methicillin-resistant Staphylococcus aureus prevalence in a hospital-based palliative care unit. Palliat Med 2016; 30: 703-706.
van Nordennen RT, Lavrijsen JC, Vissers KC, et al. Decision Making About Change of Medication for Comorbid Disease at the End of Life: An Integrative Review. Drugs Aging 2014; 31: 501-512.
Szczerbińska K. Quality of palliative care in long-term care facilities in Poland. Results from the PACE study 1. International Conference “End-of-life care for older people in long-term care facilities” 31.03-1.04.2017 Kraków.
Albrecht JS, McGregor JC, Fromme EK, et al. A nationwide analysis of antibiotic use in hospice care in the final week of life. J Pain Symptom Manage 2013; 46: 483-490.
Rosenberg JH, Albrecht JS, Fromme EK, et al. Antimicrobial Use for Symptom Management in Patients Receiving Hospice and Palliative Care: A Systematic Review. J Palliat Med 2013; 16: 1568-1574.
Helde-Frankling M, Bergqvist J, Bergman P, et al. Antibiotic Treatment in End-of-Life Cancer Patients – A Retrospective Observational Study at a Palliative Care Center in Sweden. Cancers 2016; 8: 84.
Merel SE, Meier CA, McKinney CM, et al. Antimicrobial Use in Patients on a Comfort Care Protocol: A Retrospective Cohort Study J Palliat Med. 2016; 19: 1210-1214.
Schwartz DN, Abiad H, DeMarais PL, et al. An educational intervention to improve antimicrobial use in a hospital-based long-term care facility. J Am Geriatr Soc 2007; 55: 1236-1242.
Scales K, Zimmerman S, Reed D, et al. Nurse and Medical Provider Perspectives on Antibiotic Stewardship in Nursing Homes. J Am Geriatr Soc 2016; 65: 165-171.
Ford PJ, Fraser TG, Davis MP, et al. Ati-infective therapy at end of life: Ethical decision-making in hospice-eligible patients. Bioethics 2005; 19: 379-392.
Twycross R, Wilcock A, Hoard P (eds.). Palliative Care Formulary (5th ed). Retrieved from: palliativedrugs.com.
Spurling GKP, DelMar CB, Dooley L, et al. Delayed antibiotics for respiratory infections. Cochrane Database Syst Rev 2013; CD004417, doi: 10.1002/14651858.CD004417.pub4.
Alsirafy SA, El Mesidy SM, Abou-Elela EN, et al. Naproxen test for neoplastic fever may reduce suffering. J Palliat Med 2011; 14: 665-667.
Reinbolt RE, Shenk AM, White PH, et al. Symptomatic treatment of infections in patients with advanced cancer receiving hospice care. J Pain Symptom Manage 2005; 30: 175-182.
Givens JL, Jones RN, Shaffer ML, et al. Survival and comfort after treatment of pneumonia in advanced dementia. Arch Intern Med 2010; 170: 1102-1107.
Clayton J, Fardell B, Hutton-Potts J, et al. Parenteral antibiotics in a palliative care unit: prospective analysis of current practice. Palliat Med 2003; 17; 44-48.
Spruyt O, Kausae A. Antibiotic use for infective terminal respiratory Secretions (letter). J Pain Symptom Manage 1998; 15: 263-264.
Quick links
© 2018 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe